Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab

AIM: To report the change in visual acuity and central macular thickness (CMT) following treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration (nAMD) with suboptimum response to ranibizumab. METHODS: This was a retrospective study. The incl...

Full description

Bibliographic Details
Main Authors: Rachel Hui Fen Lim, Bhaskar Gupta, Peter Simcock
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2017-03-01
Series:International Journal of Ophthalmology
Subjects:
aflibercept
ranibizumab
neovascular age-related macular degeneration
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360778/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360778/

Similar Items